Long Term Efficacy and Safety of Laronidase for MPS I
Aug 4, 2009
00:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Guest: Emil Kakkis, MD, PhD
Host: Bruce Bloom, DDS, JD
Host Dr. Bruce Bloom welcomes Dr. Emil Kakkis, an advisor at BioMarin Pharmaceutical Inc. and author of numerous published articles on mucopolysaccharidosis I, or MPS I, to discuss current treatment options. They discuss the benefits and risks of enzyme replacement therapy with laronidase.
Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:
